Filing exhibits
- 8-K Current report
- 2.2 Certificate of Merger As Filed with the Delaware Secretary of State Effective October 28, 2022
- 3.1 Amended and Restated Certificate of Incorporation of Coeptis Therapeutics Holdings, Inc.
- 3.3 Amended and Restated Bylaws of Coeptis Therapeutics Holdings, Inc.
- 4.1 2022 Equity Incentive Plan
- 21.1 Subsidiaries of Coeptis Therapeutics Holdings, Inc.
- 23.1 Consent of Independent Registered Public Accounting Firm
- 99.1 Audited Financial Statements of Coeptis Therapeutics, Inc.
- 99.2 Unaudited Pro Forma Condensed Combined Financial Statements for the Year Ended December 31, 2021 and As of and for the Six Months Ended June 30, 2022
- 99.3 Coeptis Therapeutics Holdings Inc. Presentation
- 99.4 Coeptis Therapeutics Inc. Press Release Dated October 31, 2022
- 99.5 Coeptis Therapeutics Holdings Inc. Press Release Dated November 2, 2022
- Download Excel data file
- View Excel data file
Table of Contents